Cargando…

Comparative evaluation of iodine-131 metaiodobenzylguanidine and 18-fluorodeoxyglucose positron emission tomography in assessing neural crest tumors: Will they play a complementary role?

BACKGROUND: 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) has established a role in the evaluation of several malignancies. However, its precise clinical role in the neural crest cell tumors continues to evolve. PURPOSE: The purpose of this study was to compare iodine-131 metaiodobenz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kundu, Soumyakanti, Kand, Purushottam, Basu, Sandip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	ORIGINAL ARTICLE: Diagnostics in Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379891/ https://www.ncbi.nlm.nih.gov/pubmed/28413794 http://dx.doi.org/10.4103/2278-330X.202556

Ejemplares similares

Myocardial uptake of F-18-fluorodeoxyglucose in whole body positron emission tomography studies
por: Tiwari, Bijaynath P, et al.
Publicado: (2012)

Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective
por: Kayano, Daiki, et al.
Publicado: (2015)

The efficacy and safety of Iodine-131-metaiodobenzylguanidine therapy in patients with neuroblastoma: a meta-analysis
por: He, Huihui, et al.
Publicado: (2022)

Follicular thyroid carcinoma metastasizing to rare sites and exhibiting variable inter-lesional heterogeneity on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and (131)I
por: Parghane, Rahul V., et al.
Publicado: (2020)

Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapy
por: d’Amico, Andrea
Publicado: (2014)

OR29-3 High-specific-activity Iodine 131 Metaiodobenzylguanidine for the Treatment of Advanced Pheochromocytoma and Paraganglioma: A Real-world Study
por: Al-ward, Ruaa
Publicado: (2022)

Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in idiopathic pulmonary fibrosis: A new ray of hope!
por: Desai, Unnati, et al.
Publicado: (2016)

Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine
por: Jimenez, Camilo, et al.
Publicado: (2019)

Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours
por: Nwosu, A C, et al.
Publicado: (2008)

The role of (131)I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
por: Schoot, Reineke A., et al.
Publicado: (2013)

(18)F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary: A subgroup-specific analysis based on clinical presentation
por: Thapa, Pradeep, et al.
Publicado: (2018)

(131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients
por: Garaventa, A, et al.
Publicado: (1999)

Discordant Primary Resistance to Imatinib Mesylate in the Same Individual and Splenic Involvement in Recurring Gastric Gastrointestinal Stromal Tumors: Assessment by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
por: Fargose, Preeti, et al.
Publicado: (2018)

Complete remission of metastatic pheochromocytoma in (123)I-metaiodobenzylguanidine scintigraphy after a single session of (131)I-metaiodobenzylguanidine therapy: a case report
por: Sugino, Teruaki, et al.
Publicado: (2017)

Designing and Comparing Performances of Image Processing Pipeline for Enhancement of I-131-metaiodobenzylguanidine Images
por: Pandey, Anil Kumar, et al.
Publicado: (2021)

Hepatic Pseudolymphoma with Fluorodeoxyglucose Uptake on Positron Emission Tomography
por: Suzumura, Kazuhiro, et al.
Publicado: (2017)

Fluorodeoxyglucose positron emission tomography in pyrexia of unknown origin
por: Angamuthu, Meivel, et al.
Publicado: (2020)

Fluorodeoxyglucose-positron emission tomography in carcinoma nasopharynx: Can we predict outcomes and tailor therapy based on postradiotherapy fluorodeoxyglucose-positron emission tomography?
por: Laskar, Sarbani Ghosh, et al.
Publicado: (2016)

Toxicity of upfront (131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis
por: Bleeker, Gitta, et al.
Publicado: (2013)

Feasibility of High-dose Iodine-131-metaiodobenzylguanidine Therapy for High-risk Neuroblastoma Preceding Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation: a Study Protocol
por: Araki, Raita, et al.
Publicado: (2018)

I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma
por: Sato, Yuya, et al.
Publicado: (2012)

Diagnosis of prostatitis by 18-F-fluorodeoxyglucose positron emission tomography
por: Ho, Thien Anh, et al.
Publicado: (2009)

Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Disseminated Cryptococcosis
por: Tripathy, Sarthak, et al.
Publicado: (2017)

Pulmonary “Finger-in-glove” Sign on Fluorodeoxyglucose-positron Emission Tomography
por: Yanagisawa, Satoru, et al.
Publicado: (2019)

Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020)

Neurolymphomatosis detected by (18)F‐fluorodeoxyglucose‐positron emission tomography
por: Hori, Yoshikazu, et al.
Publicado: (2020)

Fluorodeoxyglucose Positron Emission Tomography Imaging in Pneumocystis jiroveci Pneumonia
por: Rathore, Hemant, et al.
Publicado: (2022)

The Frequency of Focal Thyroid Incidental Findings and Risk of Malignancy Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography in an Iodine Deficient Population
por: Gedberg, Nina, et al.
Publicado: (2018)

Bilateral Diffuse Fluorodeoxyglucose Uptake in Thyroid Gland Diagnosed by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
por: Win, Aung Zaw, et al.
Publicado: (2014)

Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse
por: Hain, S F, et al.
Publicado: (2000)

Initial evaluation of inflammatory breast cancer with fluorodeoxyglucose positron emission tomography
por: Sager, Sait, et al.
Publicado: (2012)

Risk of Malignancy in Thyroid Incidentalomas Identified by Fluorodeoxyglucose-Positron Emission Tomography
por: Chun, A Reum, et al.
Publicado: (2015)

(18)F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies
por: Graff-Radford, Jonathan, et al.
Publicado: (2020)

Gallbladder lymphoma detected by (18)F-fluorodeoxyglucose positron emission tomography
por: So, Alvin, et al.
Publicado: (2020)

Congruence of Ga-68 Dotanoc positron emission tomography-computed tomography and metaiodobenzylguanidine scan in a patient of metastatic medullary thyroid carcinoma
por: Krishnamurthy, Arvind, et al.
Publicado: (2012)

Metastatic vertebral lesion mimicking an atypical hemangioma with negative 18F-FDG positron emission tomography-computed tomography
por: Paladino, Lucas Paul, et al.
Publicado: (2019)

Grade 3 metastatic neuroendocrine neoplasms of two unusual primary sites with contrasting differentiation characteristics: Dual tracer positron emission tomography and computed tomography imaging ((18)F-fluorodeoxyglucose and (68)Ga-DOTATATE) correlates and their treatment implications
por: Loharkar, Sarvesh, et al.
Publicado: (2020)

Evaluating cardiac hypoxia in hibernating myocardium: Comparison of (99m)Tc-MIBI/(18)F-fluorodeoxyglucose and (18)F-fluoromisonidazole positron emission tomography-computed tomography in relation to normal, hibernating, and infarct myocardium
por: Jagtap, Rajlaxmi, et al.
Publicado: (2019)

Iodine-131 and Thyroid Function
por: Sun, Wenjie
Publicado: (2014)

Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
por: Zhu, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ks3851bri262mmlm5cjs4kfih8